Vyvanse Approved for Adult ADHD
Vyvanse has been FDA approved for the treatment of ADHD in children aged 6 to 12 since July of 2007. Shire announced on April 23, 2008 that it had received approval from the FDA for the treatment of ADHD in adults. Shire also markets Adderall XR, which also has FDA approval for treatment of adult ADHD.
A four week study of 414 adults aged 18 to 55 years old with ADHD found significant improvement in ADHD symptoms after one week. Doses studied were 30 mg, 50 mg, and 70 mg. The Clinical Global Impressions-Improvement scale, used to rate severity of illness and improvement, found that 57 to 61 percent of subjects improved across all doses. The most common side effects were decreased appetite, difficulty falling asleep, and dry mouth, according to Shire.
Related Topics:
A four week study of 414 adults aged 18 to 55 years old with ADHD found significant improvement in ADHD symptoms after one week. Doses studied were 30 mg, 50 mg, and 70 mg. The Clinical Global Impressions-Improvement scale, used to rate severity of illness and improvement, found that 57 to 61 percent of subjects improved across all doses. The most common side effects were decreased appetite, difficulty falling asleep, and dry mouth, according to Shire.
Related Topics:
1 Comments:
My child has recently began taking vyvance and i have noticed that she has begun loosing her hair. Is this a side effect that anyone else has noticed with their child??? It is not listed as a possible side effect on the drug info....
Post a Comment